Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution
Menu

Contact Us
If you have any questions or feedback please contact us.
 Back to Profile

Scott Berkowitz

Concepts (377)

Concepts are derived automatically from a person's publications.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Rivaroxaban
108
2023
211
11.410
 Why?
Factor Xa Inhibitors
69
2022
138
5.900
 Why?
Anticoagulants
73
2022
546
4.950
 Why?
Stroke
67
2022
1015
4.680
 Why?
Aspirin
47
2023
324
4.580
 Why?
Atrial Fibrillation
43
2021
325
4.130
 Why?
Warfarin
39
2021
135
3.730
 Why?
Platelet Aggregation Inhibitors
46
2023
399
3.660
 Why?
Peripheral Arterial Disease
26
2023
380
3.550
 Why?
Hemorrhage
59
2023
618
3.310
 Why?
Intracranial Embolism
17
2021
29
2.610
 Why?
Morpholines
27
2021
101
2.470
 Why?
Venous Thromboembolism
16
2022
231
2.450
 Why?
Thiophenes
26
2021
108
2.420
 Why?
Embolism
17
2021
43
1.780
 Why?
Drug Monitoring
7
2021
184
1.670
 Why?
Arthroplasty, Replacement, Hip
9
2020
109
1.650
 Why?
Risk Adjustment
3
2020
75
1.550
 Why?
Double-Blind Method
60
2021
1665
1.540
 Why?
Vitamin K
15
2017
42
1.170
 Why?
Myocardial Infarction
18
2023
931
1.160
 Why?
Aged
108
2022
19135
1.060
 Why?
Arthroplasty, Replacement, Knee
11
2020
246
1.060
 Why?
Endovascular Procedures
5
2022
268
1.050
 Why?
Lower Extremity
11
2022
337
1.050
 Why?
Thrombosis
4
2022
302
1.040
 Why?
Brain Ischemia
9
2022
297
1.010
 Why?
Treatment Outcome
69
2022
9151
0.960
 Why?
Drug Therapy, Combination
28
2023
959
0.930
 Why?
Enoxaparin
12
2020
52
0.880
 Why?
Thromboembolism
8
2020
93
0.860
 Why?
Heparin
14
2003
222
0.850
 Why?
Coronary Disease
12
2021
347
0.850
 Why?
Fibrinolytic Agents
10
2022
233
0.830
 Why?
Coronary Artery Disease
8
2021
607
0.830
 Why?
Thrombolytic Therapy
6
2017
118
0.790
 Why?
Middle Aged
82
2021
26872
0.760
 Why?
Brain Infarction
5
2021
22
0.750
 Why?
Venous Thrombosis
10
2020
145
0.740
 Why?
Male
115
2022
55813
0.730
 Why?
Platelet Glycoprotein GPIIb-IIIa Complex
8
2002
22
0.710
 Why?
Thrombocytopenia
11
2003
178
0.700
 Why?
Female
112
2022
59719
0.680
 Why?
Humans
161
2023
115221
0.670
 Why?
Postoperative Complications
6
2021
2158
0.670
 Why?
Ischemia
7
2023
363
0.620
 Why?
Administration, Oral
23
2021
731
0.590
 Why?
Drug-Related Side Effects and Adverse Reactions
1
2020
242
0.590
 Why?
Risk Factors
39
2022
8658
0.560
 Why?
Blood Coagulation
9
2020
221
0.560
 Why?
Risk Assessment
17
2021
2981
0.560
 Why?
Cardiovascular Diseases
9
2021
1731
0.520
 Why?
Angioplasty, Balloon, Coronary
8
2003
146
0.510
 Why?
Blood Transfusion
4
2014
276
0.480
 Why?
Prothrombin Time
5
2020
34
0.480
 Why?
Immunoglobulin Fab Fragments
7
2002
69
0.470
 Why?
Dose-Response Relationship, Drug
16
2021
1860
0.450
 Why?
Pulmonary Embolism
8
2020
184
0.440
 Why?
Biomarkers, Pharmacological
3
2020
26
0.400
 Why?
Drug Administration Schedule
15
2021
721
0.400
 Why?
Cerebral Hemorrhage
3
2021
96
0.390
 Why?
Surgical Wound Infection
1
2014
248
0.380
 Why?
Recurrence
11
2021
952
0.340
 Why?
Secondary Prevention
6
2020
222
0.330
 Why?
Plaque, Atherosclerotic
2
2020
44
0.320
 Why?
Antibodies, Monoclonal
8
2002
1268
0.320
 Why?
Aged, 80 and over
22
2021
6358
0.320
 Why?
Heart Valve Prosthesis Implantation
2
2001
175
0.320
 Why?
Vascular Surgical Procedures
2
2021
261
0.310
 Why?
Models, Statistical
3
2020
603
0.310
 Why?
Prognosis
6
2021
3336
0.300
 Why?
Angina, Unstable
4
2003
72
0.290
 Why?
Incidence
11
2021
2324
0.290
 Why?
Gastrointestinal Hemorrhage
2
2019
102
0.280
 Why?
Vascular Diseases
2
2021
231
0.280
 Why?
Time Factors
16
2021
6157
0.260
 Why?
Platelet Aggregation
3
2002
94
0.260
 Why?
Atherosclerosis
2
2019
341
0.260
 Why?
Kaplan-Meier Estimate
9
2021
816
0.260
 Why?
Aortic Valve Insufficiency
2
2016
46
0.250
 Why?
Follow-Up Studies
13
2020
4430
0.250
 Why?
Diabetes Mellitus
5
2021
909
0.240
 Why?
Mitral Valve Insufficiency
2
2016
62
0.240
 Why?
Azetidines
4
2005
31
0.240
 Why?
International Normalized Ratio
5
2018
45
0.230
 Why?
Anti-Arrhythmia Agents
2
2015
106
0.230
 Why?
Internationality
6
2021
144
0.230
 Why?
Proportional Hazards Models
8
2021
1082
0.220
 Why?
Randomized Controlled Trials as Topic
10
2019
1214
0.220
 Why?
Intention to Treat Analysis
7
2021
68
0.220
 Why?
Arteries
2
2022
249
0.220
 Why?
Postoperative Care
2
2003
222
0.220
 Why?
Chemoprevention
2
2020
88
0.220
 Why?
Myocardial Ischemia
3
2000
237
0.210
 Why?
Antifibrinolytic Agents
2
2014
50
0.210
 Why?
Platelet Function Tests
2
2002
24
0.210
 Why?
Withholding Treatment
2
2021
69
0.210
 Why?
Acute Coronary Syndrome
2
2019
254
0.210
 Why?
Renal Insufficiency
2
2021
136
0.210
 Why?
Drug Carriers
1
2003
112
0.210
 Why?
Multimorbidity
1
2022
30
0.210
 Why?
von Willebrand Factor
4
1992
56
0.200
 Why?
Echocardiography, Transesophageal
2
2019
89
0.200
 Why?
Carotid Artery Diseases
2
2019
57
0.200
 Why?
Electrocardiography
3
2001
563
0.200
 Why?
Drug-Eluting Stents
1
2021
62
0.190
 Why?
Drug Substitution
3
2021
46
0.190
 Why?
Heart Valves
1
2001
41
0.180
 Why?
Clinical Trials as Topic
6
2016
937
0.180
 Why?
Therapeutic Index
1
2020
2
0.180
 Why?
Paclitaxel
1
2021
190
0.180
 Why?
Intracranial Arteriosclerosis
1
2020
8
0.180
 Why?
Troponin T
1
2020
49
0.180
 Why?
Kidney
2
2017
1188
0.170
 Why?
Point-of-Care Systems
2
2014
140
0.170
 Why?
Comorbidity
6
2021
1458
0.170
 Why?
Thrombophlebitis
2
1997
8
0.160
 Why?
Tyrosine
1
2000
216
0.160
 Why?
Intracranial Hemorrhages
3
2019
76
0.160
 Why?
Cardiomegaly
1
2020
160
0.160
 Why?
Prospective Studies
12
2021
6245
0.160
 Why?
Polypharmacy
2
2016
74
0.150
 Why?
Peptide Fragments
5
2003
668
0.150
 Why?
Heart Failure
6
2021
1962
0.150
 Why?
Coronary Thrombosis
3
2016
25
0.150
 Why?
Brain
2
2020
2378
0.150
 Why?
Partial Thromboplastin Time
4
2014
51
0.150
 Why?
Foramen Ovale, Patent
1
2018
45
0.150
 Why?
Antigens
1
1999
318
0.150
 Why?
Body Mass Index
3
2021
1968
0.150
 Why?
Antibodies, Monoclonal, Humanized
2
2020
665
0.150
 Why?
Heart Diseases
1
2021
331
0.150
 Why?
Neoplasms
3
2020
2106
0.140
 Why?
Ischemic Attack, Transient
1
2018
61
0.140
 Why?
Overweight
1
2021
475
0.140
 Why?
Aorta, Thoracic
1
2019
261
0.140
 Why?
Surgery, Oral
1
1996
6
0.140
 Why?
Orthodontic Appliances
1
1996
10
0.140
 Why?
Calcium Channel Blockers
1
2017
115
0.140
 Why?
Drug Discovery
2
2015
124
0.140
 Why?
Prevalence
5
2021
2257
0.140
 Why?
Cleft Lip
1
1996
31
0.140
 Why?
Cognitive Dysfunction
1
2020
273
0.130
 Why?
Cleft Palate
1
1996
45
0.130
 Why?
Angioplasty, Balloon
1
1997
89
0.130
 Why?
Clinical Trials, Phase III as Topic
4
2019
83
0.130
 Why?
Digoxin
1
2015
26
0.120
 Why?
Multivariate Analysis
6
2016
1436
0.120
 Why?
Biomarkers
3
2020
3422
0.120
 Why?
Factor X
1
2014
24
0.120
 Why?
Prothrombin
1
2014
22
0.120
 Why?
Factor IX
1
2014
34
0.120
 Why?
Factor VII
1
2014
26
0.120
 Why?
Adult
16
2020
30710
0.120
 Why?
Amiodarone
1
2014
23
0.120
 Why?
Blood Coagulation Factors
1
2014
44
0.120
 Why?
Cognition Disorders
1
2018
475
0.120
 Why?
Severity of Illness Index
5
2021
2552
0.120
 Why?
Defibrillators, Implantable
1
2017
286
0.110
 Why?
Cardiovascular Agents
1
2015
125
0.110
 Why?
Models, Biological
2
2019
1638
0.110
 Why?
Mortality
3
2021
287
0.110
 Why?
Recombinant Proteins
4
2015
1237
0.110
 Why?
Sex Factors
4
2021
1722
0.110
 Why?
Elective Surgical Procedures
1
2014
153
0.110
 Why?
Hematoma
1
2013
50
0.110
 Why?
Arthroplasty, Replacement, Ankle
1
2012
26
0.100
 Why?
von Willebrand Diseases
2
1990
11
0.100
 Why?
Hirudins
2
2003
46
0.100
 Why?
Retrospective Studies
10
2018
12596
0.100
 Why?
Heparin, Low-Molecular-Weight
2
2005
27
0.100
 Why?
Quality of Life
1
2022
2364
0.090
 Why?
Survival Rate
4
2020
1650
0.090
 Why?
Peptides
4
2002
849
0.090
 Why?
Percutaneous Coronary Intervention
1
2016
445
0.090
 Why?
Continuity of Patient Care
1
2013
253
0.090
 Why?
Age Factors
4
2018
2900
0.090
 Why?
Latin America
2
2021
69
0.090
 Why?
Hospitalization
2
2016
1754
0.090
 Why?
Prodrugs
3
2005
43
0.090
 Why?
Obesity, Morbid
1
2013
199
0.090
 Why?
Factor Xa
3
2015
32
0.090
 Why?
Acute Disease
5
2021
918
0.090
 Why?
Chemical and Drug Induced Liver Injury
1
2011
125
0.080
 Why?
Magnetic Resonance Imaging
4
2021
3128
0.080
 Why?
Single-Blind Method
2
2020
258
0.080
 Why?
Predictive Value of Tests
3
2021
1816
0.080
 Why?
Tissue Plasminogen Activator
3
2022
227
0.080
 Why?
Sialic Acids
1
1988
7
0.080
 Why?
Thrombin
2
2014
141
0.080
 Why?
Obesity
1
2021
2525
0.080
 Why?
Pancreatic Elastase
1
1988
67
0.080
 Why?
Calpain
1
1988
53
0.080
 Why?
Hypertension
1
2016
1060
0.080
 Why?
Logistic Models
4
2021
1841
0.080
 Why?
Peptide Hydrolases
1
1988
106
0.070
 Why?
Platelet Transfusion
2
1999
65
0.070
 Why?
Platelet Count
2
1998
83
0.070
 Why?
Anti-Inflammatory Agents, Non-Steroidal
2
2021
299
0.070
 Why?
Drug Approval
2
2015
78
0.070
 Why?
Adolescent
8
2020
17889
0.070
 Why?
Cohort Studies
3
2022
4917
0.070
 Why?
United States Food and Drug Administration
2
2015
173
0.070
 Why?
International Cooperation
2
2018
172
0.070
 Why?
Magnetic Resonance Angiography
2
2019
240
0.070
 Why?
Drug Combinations
2
2019
287
0.070
 Why?
Preoperative Care
2
2020
319
0.070
 Why?
Europe
2
2019
336
0.070
 Why?
Infusions, Intravenous
2
1998
372
0.070
 Why?
Injections, Subcutaneous
3
2010
133
0.060
 Why?
Combined Modality Therapy
2
2020
1130
0.060
 Why?
Purinergic P2Y Receptor Antagonists
2
2018
62
0.060
 Why?
Creatinine
2
2017
428
0.060
 Why?
United States
5
2019
12256
0.060
 Why?
Benzylamines
4
2005
39
0.060
 Why?
Forecasting
2
2013
333
0.060
 Why?
Safety
3
2000
298
0.060
 Why?
Child
5
2020
18468
0.060
 Why?
Pharmacokinetics
1
2003
25
0.060
 Why?
Body Weight
2
1998
875
0.060
 Why?
Caprylates
1
2003
19
0.060
 Why?
Cause of Death
2
2016
367
0.050
 Why?
Myocardial Revascularization
2
2000
67
0.050
 Why?
Numbers Needed To Treat
1
2021
8
0.050
 Why?
Multicenter Studies as Topic
2
2000
247
0.050
 Why?
Mobility Limitation
1
2022
60
0.050
 Why?
Infant
3
2020
7966
0.050
 Why?
Injections, Intravenous
2
2000
202
0.050
 Why?
Pipecolic Acids
1
2001
23
0.050
 Why?
Intermittent Claudication
1
2022
108
0.050
 Why?
Hirudin Therapy
1
2000
2
0.050
 Why?
Child, Preschool
3
2020
9124
0.050
 Why?
Antithrombins
1
2000
49
0.050
 Why?
Antineoplastic Agents, Phytogenic
1
2021
181
0.040
 Why?
Patient Safety
2
2013
277
0.040
 Why?
Streptokinase
2
1997
11
0.040
 Why?
Stents
2
2002
476
0.040
 Why?
Clinical Trials, Phase II as Topic
1
2019
57
0.040
 Why?
Acetates
1
2000
95
0.040
 Why?
Heart Valve Diseases
1
2001
159
0.040
 Why?
Heart Atria
1
2020
111
0.040
 Why?
Cerebral Angiography
1
2019
111
0.040
 Why?
Drug Dosage Calculations
1
2019
21
0.040
 Why?
Global Health
1
2021
288
0.040
 Why?
Monitoring, Physiologic
1
2001
249
0.040
 Why?
Pyridones
1
2020
125
0.040
 Why?
MEDLINE
1
2018
22
0.040
 Why?
Health Status Disparities
1
2021
202
0.040
 Why?
Diagnostic Tests, Routine
1
2019
87
0.040
 Why?
Blood Pressure
2
2016
1540
0.040
 Why?
Sex Distribution
2
2015
337
0.040
 Why?
Coronary Artery Bypass
1
2000
196
0.040
 Why?
Disease-Free Survival
1
2020
619
0.040
 Why?
Arginine
2
2015
238
0.040
 Why?
Australia
1
2019
206
0.040
 Why?
Computed Tomography Angiography
1
2019
100
0.040
 Why?
Antibody Formation
1
1999
267
0.040
 Why?
Walking
1
2022
424
0.040
 Why?
Dermatan Sulfate
1
1997
3
0.040
 Why?
Placebos
1
1998
198
0.040
 Why?
Catheters, Indwelling
1
1998
79
0.040
 Why?
Infant, Newborn
2
2020
5052
0.040
 Why?
Heparitin Sulfate
1
1997
39
0.040
 Why?
Chondroitin Sulfates
1
1997
33
0.040
 Why?
Alanine Transaminase
2
2011
141
0.040
 Why?
Statistics, Nonparametric
1
2018
387
0.040
 Why?
Ligands
1
1999
565
0.040
 Why?
Hemodilution
1
1997
10
0.040
 Why?
Diltiazem
1
2017
23
0.040
 Why?
Verapamil
1
2017
32
0.040
 Why?
Blood Transfusion, Autologous
1
1997
19
0.040
 Why?
Hip Prosthesis
1
1997
33
0.040
 Why?
Postoperative Period
2
2013
293
0.040
 Why?
Glomerular Filtration Rate
1
2020
605
0.040
 Why?
Recombinant Fusion Proteins
1
2000
616
0.040
 Why?
Knee Prosthesis
1
1997
15
0.030
 Why?
Gingivoplasty
1
1996
1
0.030
 Why?
Alveoloplasty
1
1996
2
0.030
 Why?
Pyrazoles
1
2020
361
0.030
 Why?
Morbidity
1
2017
279
0.030
 Why?
Lip
1
1996
20
0.030
 Why?
China
1
2017
163
0.030
 Why?
Maxillofacial Development
1
1996
18
0.030
 Why?
Kidney Function Tests
1
2017
141
0.030
 Why?
Survival Analysis
1
2000
1215
0.030
 Why?
Clinical Decision-Making
1
2019
268
0.030
 Why?
Cardiopulmonary Bypass
1
1997
176
0.030
 Why?
Thrombophilia
1
2016
66
0.030
 Why?
Blood Platelets
1
1998
352
0.030
 Why?
Bone Transplantation
1
1996
99
0.030
 Why?
Geography
1
2016
181
0.030
 Why?
Anxiety Disorders
1
2018
307
0.030
 Why?
Depressive Disorder
1
2018
333
0.030
 Why?
Federal Government
1
2015
26
0.030
 Why?
Death, Sudden
1
2015
27
0.030
 Why?
Government Regulation
1
2015
46
0.030
 Why?
Animals
5
2013
31884
0.030
 Why?
Drug Industry
1
2015
104
0.030
 Why?
Area Under Curve
1
2014
275
0.030
 Why?
Chronic Disease
1
2019
1594
0.030
 Why?
Healthy Volunteers
1
2014
197
0.030
 Why?
Congresses as Topic
1
2015
200
0.030
 Why?
Risk
1
2016
816
0.030
 Why?
North America
1
2014
259
0.030
 Why?
Hemarthrosis
1
2012
11
0.030
 Why?
Piperazines
1
2015
313
0.030
 Why?
Neurotransmitter Agents
1
2013
77
0.030
 Why?
Comparative Effectiveness Research
1
2013
130
0.030
 Why?
Algorithms
1
1999
1488
0.030
 Why?
Plasma
1
2014
210
0.030
 Why?
Aortic Valve Stenosis
1
2016
272
0.030
 Why?
Clinical Protocols
1
2013
234
0.020
 Why?
Evidence-Based Medicine
1
2016
676
0.020
 Why?
Heart Rate
1
2015
705
0.020
 Why?
Cognition
1
2018
982
0.020
 Why?
Validation Studies as Topic
1
2011
23
0.020
 Why?
Acenocoumarol
1
2010
1
0.020
 Why?
Bilirubin
1
2011
89
0.020
 Why?
Liver Function Tests
1
2011
106
0.020
 Why?
Adverse Drug Reaction Reporting Systems
1
2011
68
0.020
 Why?
Alkaline Phosphatase
1
2011
144
0.020
 Why?
Patient Selection
1
2014
651
0.020
 Why?
Drug Design
1
2011
151
0.020
 Why?
Syndrome
2
2002
338
0.020
 Why?
Tomography, X-Ray Computed
1
2019
2344
0.020
 Why?
Phlebography
1
2009
40
0.020
 Why?
Biomedical Research
1
2015
585
0.020
 Why?
Registries
1
2016
1765
0.020
 Why?
Macromolecular Substances
1
1988
200
0.020
 Why?
Molecular Targeted Therapy
1
2011
347
0.020
 Why?
Coronary Angiography
2
2001
307
0.020
 Why?
Amino Acid Sequence
2
1990
1990
0.020
 Why?
Structure-Activity Relationship
1
1988
503
0.020
 Why?
Risk Reduction Behavior
1
2009
201
0.020
 Why?
Research Design
1
2013
933
0.020
 Why?
Molecular Structure
1
1988
438
0.020
 Why?
In Vitro Techniques
1
1988
1036
0.020
 Why?
Epitopes
1
1988
436
0.020
 Why?
Analysis of Variance
1
2009
1231
0.020
 Why?
Models, Molecular
1
2011
1379
0.020
 Why?
Blotting, Western
1
1988
1150
0.020
 Why?
Cross-Sectional Studies
1
2016
4419
0.020
 Why?
Sensitivity and Specificity
1
2009
1717
0.010
 Why?
Mice
1
2000
14934
0.010
 Why?
Hemostatics
1
2003
48
0.010
 Why?
Random Allocation
1
2003
336
0.010
 Why?
Drug Resistance
1
2002
159
0.010
 Why?
Purpura
1
2001
13
0.010
 Why?
Wound Healing
1
2003
259
0.010
 Why?
Statistics as Topic
1
2002
298
0.010
 Why?
Blood Coagulation Tests
1
2001
57
0.010
 Why?
Angina Pectoris
1
2000
63
0.010
 Why?
Immunoblotting
2
1992
282
0.010
 Why?
Exanthema
1
2001
77
0.010
 Why?
Diarrhea
1
2001
171
0.010
 Why?
Mutation
1
1990
3350
0.010
 Why?
Confidence Intervals
1
2000
307
0.010
 Why?
Age Distribution
1
2000
341
0.010
 Why?
Probability
1
2000
290
0.010
 Why?
Young Adult
1
2014
10519
0.010
 Why?
Equipment Design
1
2001
513
0.010
 Why?
Sulfonamides
1
2001
445
0.010
 Why?
Odds Ratio
1
2000
958
0.010
 Why?
Hematocrit
1
1997
85
0.010
 Why?
Pain
1
2001
709
0.010
 Why?
Health Care Costs
1
1998
381
0.010
 Why?
Length of Stay
1
1998
951
0.010
 Why?
Disease Progression
1
2000
2390
0.010
 Why?
Ristocetin
1
1992
1
0.010
 Why?
Urokinase-Type Plasminogen Activator
1
1992
28
0.010
 Why?
Fibrinolysin
1
1992
15
0.010
 Why?
Oligonucleotide Probes
1
1990
54
0.010
 Why?
Polymerase Chain Reaction
1
1990
1000
0.000
 Why?
Amino Acids
1
1990
451
0.000
 Why?
Base Sequence
1
1990
2120
0.000
 Why?
Molecular Sequence Data
1
1990
2797
0.000
 Why?
DNA
1
1990
1353
0.000
 Why?
Berkowitz's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (377) concept(s)
_
Co-Authors Expand Description
See all (9) people
_
Similar People Expand Description
See all (60) people
_
Same Department Expand Description
Search Department

Copyright © 2025 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)